HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats.

Abstract
We determined the effect of a short-term angiotensin II signaling blockade on vascular endothelial growth factor (VEGF), soluble intercellular adhesion molecule-1 (sICAM-1), nitric oxide (NO), and malondialdehyde (MDA) (index of lipid peroxidation) levels in the systemic circulation and on peroxynitrite generation and insulitis development in the streptozotocin (STZ) diabetic rats' pancreas. Diabetes was induced in Wistar rats by intraperitoneal STZ injection. Diabetic rats were treated for 1 week with losartan (20 mg/kg/body weight/day in the drinking water), and pancreas and blood were collected for histochemical, immunohistochemical, and biochemical studies. Diabetic rats showed greater VEGF, sICAM-1, NO, and MDA levels, a high score of insulitis, increased nitrotyrosine staining, and markedly reduced pancreatic insulin content when compared with controls. Losartan treatment suppressed the excessive NO and lipid peroxidation production systemically without restoring them to that of healthy subjects and reduced VEGF levels while leaving sICAM-1 levels unchanged. The insulitis score and nitrotyrosine staining were reduced, whereas the pancreatic islets and the beta-cell area were increased significantly in the treated group, indicating the reduction of inflammation and nitrosative stress and an early regeneration of beta-cell mass in the pancreas. Conclusively, in the STZ diabetic rat model, even a short-term losartan treatment improves oxidative and nitrosative stress systemically and locally, improving the islets' environment and accelerating beta-cell regeneration.
AuthorsMaria Kamper, Olia Tsimpoukidi, Antonios Chatzigeorgiou, Maria Lymberi, Elli F Kamper
JournalTranslational research : the journal of laboratory and clinical medicine (Transl Res) Vol. 156 Issue 1 Pg. 26-36 (Jul 2010) ISSN: 1878-1810 [Electronic] United States
PMID20621034 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Mosby, Inc. All rights reserved.
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Antioxidants
  • Blood Glucose
  • Nitrates
  • Vascular Endothelial Growth Factor A
  • Intercellular Adhesion Molecule-1
  • Nitric Oxide
  • Malondialdehyde
  • Streptozocin
  • Losartan
Topics
  • Angiotensin II Type 1 Receptor Blockers (pharmacology, therapeutic use)
  • Animals
  • Antioxidants (pharmacology, therapeutic use)
  • Blood Glucose
  • Body Weight
  • Diabetes Mellitus, Experimental (blood, drug therapy)
  • Intercellular Adhesion Molecule-1 (blood)
  • Losartan (pharmacology, therapeutic use)
  • Male
  • Malondialdehyde (blood)
  • Nitrates (blood, metabolism)
  • Nitric Oxide (blood)
  • Pancreas (pathology)
  • Rats
  • Rats, Wistar
  • Streptozocin
  • Vascular Endothelial Growth Factor A (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: